View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 15, 2021updated 12 Jul 2022 11:19am

ERT’s Business Intelligence suite expands to include clinical trial reporting

US-based global data and technology company eResearch Technology (ERT) has announced the expansion of its Business Intelligence suite to include reporting for clinical trial imaging, making study data easily accessible and actionable.

US-based global data and technology company eResearch Technology (ERT) has announced the expansion of its Business Intelligence suite to include reporting for clinical trial imaging, making study data easily accessible and actionable.

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

With the new imaging capabilities that provide an increased level of information, study leaders will be able to ensure completion, and manage sites, costs, and productivity effectively.

ERT Imaging vice-president Tim Kulbago said: “Imaging studies are complex, and customers are under great pressure to monitor and manage their performance. With the power of our Business Intelligence suite, study leaders can achieve the deep insights they need to act quickly, and keep studies on track for success.

“Our clinical trial imaging customers can now track their study progress all the way from first image capture to database lock, with the ability to pivot with confidence whenever a potential challenge arises.”

With ERT’s Business Intelligence suite, many CROs and sponsors can realise new operational efficiencies and better data quality.

They can also reduce study timelines and lower costs through its comprehensive views into trial performance.

The Business Intelligence suite comprises the new imaging functionality that enables customers to direct studies using existing information.

Furthermore, they have access to an easy-to-understand dashboard to evaluate early indicators of potential delays in the imaging process.

An intuitive interface of the suite allows users to access study data in various methods. Based on region, site and image reader, they can also easily filter data for a high-level view or dive down.

Additionally, through timely information study leaders can intervene as necessary.

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena